CYP24 splicing variants are associated with different patterns of constitutive and calcitriol-inducible CYP24 activity in human prostate cancer cell lines
- 31 March 2007
- journal article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 103 (3-5) , 334-337
- https://doi.org/10.1016/j.jsbmb.2006.12.060
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Colon-specific regulation of vitamin D hydroxylases—a possible approach for tumor preventionCarcinogenesis: Integrative Cancer Research, 2005
- Alternative Splicing of Vitamin D-24-HydroxylaseJournal of Biological Chemistry, 2005
- Epigenetic regulation of Vitamin D hydroxylase expression and activity in normal and malignant human prostate cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2005
- Altered Pharmacokinetics of 1α,25-Dihydroxyvitamin D3and 25-Hydroxyvitamin D3in the Blood and Tissues of the 25-Hydroxyvitamin D-24-Hydroxylase (Cyp24a1) Null MouseEndocrinology, 2005
- Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancerAnnals of Oncology, 2004
- Role of 24‐hydroxylase in vitamin D3 growth response of OVCAR‐3 ovarian cancer cellsInternational Journal of Cancer, 2003
- Quantitative mapping of amplicon structure by array CGH identifies CYP24 as a candidate oncogeneNature Genetics, 2000
- Expression and Activity of Vitamin D-Metabolizing Cytochrome P450s (CYP1α and CYP24) in Human Nonsmall Cell Lung Carcinomas*Endocrinology, 1999
- Liarozole Acts Synergistically with 1α,25-Dihydroxyvitamin D3to Inhibit Growth of DU 145 Human Prostate Cancer Cells by Blocking 24-Hydroxylase Activity1Endocrinology, 1999
- Reciprocal post-translational regulation of renal 1α- and 24-hydroxylases of 25-hydroxyvitamin D3 by phosphorylation of ferredoxin. mRNA-directed cell-free synthesis and immunoisolation of ferredoxinBiochemical Journal, 1990